These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34386424)

  • 1. The Clinical Application of Neoantigens in Esophageal Cancer.
    Gu YM; Zhuo Y; Chen LQ; Yuan Y
    Front Oncol; 2021; 11():703517. PubMed ID: 34386424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoantigens: promising targets for cancer therapy.
    Xie N; Shen G; Gao W; Huang Z; Huang C; Fu L
    Signal Transduct Target Ther; 2023 Jan; 8(1):9. PubMed ID: 36604431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoantigen vaccine: an emerging tumor immunotherapy.
    Peng M; Mo Y; Wang Y; Wu P; Zhang Y; Xiong F; Guo C; Wu X; Li Y; Li X; Li G; Xiong W; Zeng Z
    Mol Cancer; 2019 Aug; 18(1):128. PubMed ID: 31443694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Neoantigens in Cancer Immunotherapy.
    Zhu Y; Liu J
    Front Oncol; 2021; 11():682325. PubMed ID: 34513673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor neoantigens: from basic research to clinical applications.
    Jiang T; Shi T; Zhang H; Hu J; Song Y; Wei J; Ren S; Zhou C
    J Hematol Oncol; 2019 Sep; 12(1):93. PubMed ID: 31492199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Current Lung Cancer Neoantigen Landscape and Implications for Therapy.
    Ye L; Creaney J; Redwood A; Robinson B
    J Thorac Oncol; 2021 Jun; 16(6):922-932. PubMed ID: 33581342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of shared neoantigens in esophageal carcinoma by the combination of comprehensive analysis of genomic data and in silico neoantigen prediction.
    Yuan Y; Chen C; Liu S; Xiong H; Huang Y; Zhang X; Zhang X; Li B
    Cell Immunol; 2022 Jul; 377():104537. PubMed ID: 35636066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene fusion neoantigens: Emerging targets for cancer immunotherapy.
    Wang Y; Shi T; Song X; Liu B; Wei J
    Cancer Lett; 2021 May; 506():45-54. PubMed ID: 33675984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized neoantigen-based immunotherapy for advanced collecting duct carcinoma: case report.
    Zeng Y; Zhang W; Li Z; Zheng Y; Wang Y; Chen G; Qiu L; Ke K; Su X; Cai Z; Liu J; Liu X
    J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32439798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personalized T cell-mediated cancer immunotherapy: progress and challenges.
    Bethune MT; Joglekar AV
    Curr Opin Biotechnol; 2017 Dec; 48():142-152. PubMed ID: 28494274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting neoantigens for cancer immunotherapy.
    Zhao X; Pan X; Wang Y; Zhang Y
    Biomark Res; 2021 Jul; 9(1):61. PubMed ID: 34321091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neoantigen Targeting-Dawn of a New Era in Cancer Immunotherapy?
    Wirth TC; Kühnel F
    Front Immunol; 2017; 8():1848. PubMed ID: 29312332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Clinical Applications of Therapeutic Cancer Vaccines with Individualized and Shared Neoantigens.
    Hao Q; Long Y; Yang Y; Deng Y; Ding Z; Yang L; Shu Y; Xu H
    Vaccines (Basel); 2024 Jun; 12(7):. PubMed ID: 39066355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The immune landscape of esophageal cancer.
    Huang TX; Fu L
    Cancer Commun (Lond); 2019 Nov; 39(1):79. PubMed ID: 31771653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Driving neoantigen-based cancer vaccines for personalized immunotherapy into clinic: A burdensome journey to promising land.
    Yu G; He X; Li X; Wu Y
    Biomed Pharmacother; 2022 Sep; 153():113464. PubMed ID: 36076493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of neoantigens: from identification in cancer cells to application in cancer vaccines.
    Ebrahimi N; Akbari M; Ghanaatian M; Roozbahani Moghaddam P; Adelian S; Borjian Boroujeni M; Yazdani E; Ahmadi A; Hamblin MR
    Expert Rev Vaccines; 2022 Jul; 21(7):941-955. PubMed ID: 34196590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoantigens and NK Cells: "Trick or Treat" the Cancers?
    Lv D; Khawar MB; Liang Z; Gao Y; Sun H
    Front Immunol; 2022; 13():931862. PubMed ID: 35874694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy.
    Efremova M; Finotello F; Rieder D; Trajanoski Z
    Front Immunol; 2017; 8():1679. PubMed ID: 29234329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation.
    Borden ES; Buetow KH; Wilson MA; Hastings KT
    Front Oncol; 2022; 12():836821. PubMed ID: 35311072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.